AEON Biopharma, Inc. (AEON) vs GT Biopharma, Inc. (GTBP)
- AEON Biopharma, Inc. AEON 0.18 +12.50%
- GT Biopharma, Inc. GTBP 4.42 −2.64%
AEON Biopharma, Inc. and GT Biopharma, Inc. are both Biotechnology companies. AEON Biopharma, Inc. and GT Biopharma, Inc. are of similar size ($9.4M and $9.4M). AEON Biopharma, Inc. has negative trailing earnings, so its P/E is not meaningful; GT Biopharma, Inc. trades at 0.8×. Across the 7 metrics below, GT Biopharma, Inc. leads on 4 and AEON Biopharma, Inc. on 3.
Valuation
Profitability
| Metric | AEON | GTBP | Biotechnology median |
|---|---|---|---|
| Gross margin | — | 41.67% | 68.51% |
| Operating margin | 0.00% | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% | 0.00% |
| Free cash flow margin | 0.00% | 0.00% | 0.00% |
| Return on equity | 350.00% | 102.03% | (51.96%) |
| Return on assets | (621.70%) | (176.27%) | (46.06%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack